About Us

Biosynergics values quality and efficiency in all of its services. With more than over 100 cases of antibody development services to pharmaceutical businesses a...+MORE

IVD Raw Materials

Based on its proprietary antibody technology platforms (H3 antibody technology, Synergistic Antibody technology [SynAbTM]), BSI is committed to the development ...+MORE


Based on its proprietary antibody technology platforms, BSI is committed to the development of a whole new generation of unique and high quality diagnostic...+MORE

Company News

Biosynergics, Inc. Completes Series A Financing and Company Restructuring. —On October 29, 2017, Biosynergics, Inc., a China-based startup biotech...


New Products

【NEW!】Recombinant mouse anti-human cardiac troponin I (cTnI) antibody

IVD Raw Materials
For further information, please scan the QR code to follow us.
About us|Technology|Therapeutics|Products|Support|Contact Us
copyright 2015 Biosynergics Inc 苏ICP备13049856号-1